- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Non Hodgkin Lymphoma (NHL)
Total 5328 results
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Genentech, Inc.Seagen Inc.Completed
-
Eisai Inc.CompletedLymphoma, B-CellUnited States
-
Chinese PLA General HospitalRecruiting
-
Hebei Senlang Biotechnology Inc., Ltd.Hebei Medical University Fourth HospitalRecruiting
-
Burzynski Research InstituteTerminatedNon Hodgkin LymphomaUnited States
-
Case Comprehensive Cancer CenterTerminatedPrimary Central Nervous System Non-Hodgkin LymphomaUnited States
-
University of NebraskaBristol-Myers SquibbRecruitingFollicular Lymphoma | Refractory Non-Hodgkin Lymphoma | High-grade B-cell Lymphoma | DLBCL - Diffuse Large B Cell Lymphoma | Relapsed Non-Hodgkin Lymphoma | Mediastinal Large B-cell Lymphoma | Indolent B-Cell Non-Hodgkin LymphomaUnited States
-
Spectrum Pharmaceuticals, IncCTI BioPharmaTerminatedLymphoma, Follicular | Follicular LymphomaUnited States
-
University of FloridaGlaxoSmithKlineTerminatedFollicular Lymphoma | Non-Hodgkin's LymphomaUnited States
-
Hebei Senlang Biotechnology Inc., Ltd.RecruitingRefractory Indolent Adult Non-Hodgkin LymphomaChina
-
Timmune Biotech Inc.Hunan Provincial People's HospitalUnknownLeukemia | Non-Hodgkin Lymphoma of IntestineChina
-
Cellular Biomedicine Group Ltd.Shanghai Tongji Hospital, Tongji University School of MedicineUnknownRefractory or Relapsed Non-Hodgkin LymphomaChina
-
Shandong Lanjin Pharmaceuticals Co.,LtdUnknownNon-Hodgkin Lymphoma by Clinical CourseChina
-
Chongqing Precision Biotech Co., LtdPeking University Cancer Hospital & InstituteRecruitingB Cell Lymphoma | Non Hodgkin LymphomaChina
-
Thomas Jefferson UniversityNational Cancer Institute (NCI)RecruitingRecurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Indolent Adult Non-Hodgkin Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory Marginal Zone Lymphoma | Recurrent Indolent Adult Non-Hodgkin...United States
-
Medical University of South CarolinaRecruitingChronic Lymphocytic Leukemia | B-cell Non Hodgkin LymphomaUnited States
-
SymBio PharmaceuticalsCompletedNon-Hodgkin's Lymphoma | Mantle Cell LymphomaJapan
-
Henan Cancer HospitalRecruitingNon-hodgkin Lymphoma,B CellChina
-
Anne Beaven, MDCTI BioPharmaCompletedNon-Hodgkin's LymphomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Genentech, Inc.TerminatedNon-Hodgkin's LymphomaUnited States
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); The Emmes Company, LLCCompleted
-
Novartis PharmaceuticalsGlaxoSmithKlineTerminatedNon-Hodgkin's LymphomaChina, United States, Belgium, Czechia, France, Japan, Bulgaria, Canada, Hungary, Peru, Slovakia, South Africa, Ukraine, Korea, Republic of, Puerto Rico, Brazil
-
Duke UniversityGlaxoSmithKlineCompletedLymphoma, B-CellUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLCCompleted
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedStudy of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaFrance, United States, Spain, Korea, Republic of, Australia, Israel, India, Thailand, China, Czech Republic, Belgium, New Zealand, Russian Federation, Finland, South Africa, United Kingdom, Italy, Brazil, Hungary, Puerto Rico, A... and more
-
Chinese PLA General HospitalPeking University; EdiGene Inc.RecruitingNon Hodgkin's LymphomaChina
-
Sichuan Baili Pharmaceutical Co., Ltd.SystImmune Inc.; Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.RecruitingNon-hodgkin's LymphomaChina
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedMantle Cell Lymphoma | Marginal Zone Lymphoma | Non-Hodgkin Lymphoma | Small Lymphocytic Lymphoma | Lymphoproliferative Disorder | Primary Cutaneous B-Cell Non-Hodgkin Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Grade 3 Follicular... and other conditionsUnited States, Canada, Australia, Puerto Rico
-
Lundbeck Canada Inc.CompletedChronic Lymphocytic Leukemia | Indolent Non-Hodgkin's LymphomaCanada
-
University of WashingtonMerck Sharp & Dohme LLCActive, not recruitingFollicular Lymphoma | Marginal Zone Lymphoma | Indolent B-Cell Non-Hodgkin LymphomaUnited States
-
Stanford UniversityKite PharmaRecruitingNon-Hodgkin Lymphoma | Large B-cell LymphomaUnited States
-
Versailles HospitalNot yet recruitingVaccination Failure | Non-hodgkin Lymphoma,B Cell
-
Baylor College of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH); The Methodist... and other collaboratorsRecruitingLymphoma | Non-Hodgkin's Lymphoma | Hodgkin's Disease | Lymphoproliferative DiseaseUnited States
-
NCIC Clinical Trials GroupAstex Pharmaceuticals, Inc.CompletedUnspecified Adult Solid Tumor, Protocol Specific | Non-Hodgkins LymphomaCanada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Refractory T-Cell Non-Hodgkin Lymphoma | Hematopoietic Cell Transplantation RecipientUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
Jurgen BarthSponsor GmbHActive, not recruitingNon-Hodgkin's Lymphoma | Lymphocytic Lymphoma | Marginal Zone Lymphomas | Follicular Lymphomas | Immunocytomas | Mantle-Cell LymphomasGermany
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma, Solid CancersUnited States, United Kingdom
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma, Solid CancersUnited Kingdom
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma, Solid TumorCanada, United States
-
AbbVieGenentech, Inc.WithdrawnRelapsed/Refractory Non-Hodgkin's Lymphoma
-
Shanghai YingLi Pharmaceutical Co. Ltd.UnknownLymphoma, FollicularChina
-
Chinese PLA General HospitalRecruitingStudy of Chidamide, Decitabine and Immune Checkpoint Inhibitors in R/R NHL and Advanced Solid TumorsAdvanced Solid Tumors | Relapsed/Refractory Non-Hodgkin LymphomaChina
-
National Cancer Institute (NCI)RecruitingRefractory B-Cell Non-Hodgkin Lymphoma | Refractory T-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Transformed Non-Hodgkin Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Recurrent T-Cell Non-Hodgkin Lymphoma | Recurrent Primary Cutaneous... and other conditionsUnited States
-
University of NebraskaMillennium Pharmaceuticals, Inc.CompletedMantle Cell Lymphoma | Non-hodgkin's LymphomaUnited States
-
The First Affiliated Hospital of Soochow UniversityFundamenta Therapeutics, Ltd.RecruitingB Cell Lymphoma | CAR | Relapsed Non-Hodgkin LymphomaChina
-
BayerCompletedLymphoma, B-Cell | Non-Hodgkin's Lymphoma | Lymphoma, Low-GradeJapan
-
St. Jude Children's Research HospitalActive, not recruitingHodgkin Lymphoma | Myelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML) | Acute Lymphoblastic Leukemia (ALL) | Chronic Myeloid Leukemia (CML) | NK-Cell Leukemia | Non Hodgkin Lymphoma (NHL) | Juvenile Myelomonocytic Leukemia (JMML)United States